Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Treatment Interruption”

62 trials

Showing 20 of 62 results

Not applicableStudy completedNCT00238459
What this trial is testing

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 58
Testing effectiveness (Phase 2)Study completedNCT00071890
What this trial is testing

Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 148
Testing effectiveness (Phase 2)Study completedNCT00080106
What this trial is testing

Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Not applicableStudy completedNCT00016783
What this trial is testing

Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 39
Early research (Phase 1)Study completedNCT05245292
What this trial is testing

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

Who this might be right for
Human Immunodeficiency Virus
Rockefeller University 28
Large-scale testing (Phase 3)Study completedNCT00324103
What this trial is testing

Structured Treatment Interruptions in Chronic HIV Infection

Who this might be right for
HIV Infection
Istituto Superiore di Sanità 600
Early research (Phase 1)Study completedNCT06031272
What this trial is testing

Pausing Antiretroviral Treatment Under Structured Evaluation

Who this might be right for
HIV-1-infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 32
Testing effectiveness (Phase 2)Looking for participantsNCT05419024
What this trial is testing

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

Who this might be right for
HIV
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Study completedNCT00102960
What this trial is testing

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 377
Not applicableStudy completedNCT00038259
What this trial is testing

Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 21
Post-approval studies (Phase 4)Study completedNCT00646984
What this trial is testing

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Who this might be right for
HIV-Associated Lipodystrophy Syndrome
Hospital Clinic of Barcelona 147
Large-scale testing (Phase 3)Study completedNCT00025909
What this trial is testing

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 90
Post-approval studies (Phase 4)Ended earlyNCT00355251
What this trial is testing

Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 5
Not applicableLooking for participantsNCT02761200
What this trial is testing

Post Analytic Treatment Interruption Study

Who this might be right for
HIV
SEARCH Research Foundation 100
Large-scale testing (Phase 3)Study completedNCT00339456
What this trial is testing

Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 155
Early research (Phase 1)Not Yet RecruitingNCT06987318
What this trial is testing

Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT01335191
What this trial is testing

Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)

Who this might be right for
HIV Infections
Thymon, LLC 27
Testing effectiveness (Phase 2)Study completedNCT02071095
What this trial is testing

Enhancement by Poly-ICLC During HIV-1 Infection

Who this might be right for
HIV-1 Infected Adults With Chronic HIV-1 Infection
Nina Bhardwaj 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07081763
What this trial is testing

Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 191
Early research (Phase 1)Looking for participantsNCT07569029
What this trial is testing

A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 42
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation